Medical News

RSS

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Tufts University has been tapped by the United States Agency for International Development (USAID) as part of a multidisciplinary team that will receive a grant of up to $185-million to create better synergies among veterinarians, doctors, and public health officials in responding to emerging infectious diseases.

31 Oct 2009

FDA approves Covidien's Abbreviated New Drug Application for CII

Covidien, a leading global provider of healthcare products, today announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Oral Transmucosal Fentanyl Citrate (CII).

31 Oct 2009

Women may need smaller dose of H1N1 vaccine

THE emergence of the H1N1 swine flu has added urgency to what has become an annual ritual for millions of Americans: getting a flu shot. The good news is that scientists have developed a vaccine against the H1N1 virus. But it is taking much longer than expected to produce the hundreds of millions of doses the government had planned to distribute. And it is still too soon to know how effective the vaccine will be in preventing swine flu.

31 Oct 2009

NCI awards $4.8M for project to measure all the proteins in the human body

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

31 Oct 2009

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.

31 Oct 2009

Pfizer and Wyeth enter into supplemental indenture to amend consent solicitation

Pfizer today announced that it has received the requisite consents to amend certain provisions of the indenture governing the following outstanding debt securities (the Securities) of Wyeth, its wholly owned subsidiary:

31 Oct 2009

New York Times examines efforts underway to prevent spread of H1N1 during Hajj

The New York Times examines how Saudi Arabia is preparing for the upcoming annual pilgrimage of some "2.5 million people from 160 countries" to Mecca, some who "will be bringing the swine flu. The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off," the newspaper writes.

31 Oct 2009

NYBC and its divisions call upon the community to join the fight against cancer by donating blood

November is both Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and New York Blood Center (NYBC) and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call upon the community to join the fight against cancer by donating blood today.

31 Oct 2009

BHGI's approach to cancer treatment guidelines for low- and moderate-income countries

When the prestigious British medical journal The Lancet Oncology this week published six cancer treatment guideline papers aimed at the resource-diverse nations of Asia, it used as its model the economic template developed by the Breast Health Global Initiative (BHGI) based at Fred Hutchinson Cancer Research Center.

31 Oct 2009

ATLANTA-France study of the CATANIA Coronary Stent announced

Physicians at more than 40 centers in France have joined a study of the CATANIA(TM) Coronary Stent with NanoThin Polyzene®-F manufactured by CeloNova BioSciences. With Professor Emmanuel Teiger and Doctor Paul Barragan as co-Principal Investigators, the researchers today announced the Assessment of The Latest Non-Thrombogenic Angioplasty (ATLANTA-France) stent study. Each center will enroll 50 patients with the first procedures expected in early November.

31 Oct 2009

Grenadian Prime Minister calls for continued investment in Caribbean HIV/AIDS programs

During the 9th annual general meeting of the Pan Caribbean Partnership on HIV and AIDS (PANCAP) - which kicked off this week in St. George's, Grenada - Grenadian Prime Minister Tillman Thomas called on leaders in the Caribbean to maintain their commitment to HIV/AIDS in the face of the global recession, CMC/Jamaica Observer reports.

31 Oct 2009

FDA approves an expanded indication for BYETTA injection

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

31 Oct 2009

Aetna signs new expanded agreement with Sarasota Memorial Hospital

Aetna announced today that it has expanded its relationship with Sarasota Memorial Hospital by reaching agreement on a long-term contract that will provide access for Aetna’s Medicare Advantage members. This agreement marks the first time Sarasota Memorial has agreed to participate in a Medicare Advantage network plan.

31 Oct 2009

Individualized MicroNutrient Testing for patients

In response to the current trend toward personalized medicine, the Beaumont Weight Control Center, affiliated with Beaumont Hospitals, a major Detroit-area health system, now offers individualized MicroNutrient Testing for patients.

31 Oct 2009

Research suggests the possibility of an effective treatment for Hendra virus infections in humans

A scientific team from CSIRO and the US has demonstrated that administering human monoclonal antibodies after exposure to Nipah virus, which is closely related to Hendra virus, protected animals from challenge in a disease model.

31 Oct 2009

Public concern can undermine flu vaccination campaigns

The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.

31 Oct 2009

Data from multiple clinical and preclinical studies evaluating Hematide announced

Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients.

31 Oct 2009

As House bill continues to stir reaction, focus turns to costs, potential amendments

Lawmakers and various groups continue to react to the House health bill, which was released Thursday and may significantly increase federal spending on health care.

31 Oct 2009

Administration officially ends HIV travel ban

The Washington Post reports: "President Obama called the 22-year ban on travel and immigration by HIV-positive individuals a decision 'rooted in fear rather than fact' and announced the end of the rule-making process lifting the ban.

31 Oct 2009

Advocates call for increased U.S. investment in global health

A report released Thursday (.pdf) by a group of global health advocates outlines ways the U.S. can work toward increasing access to health care throughout the world, Inter Press Service reports. They call "for doubling U.S. aid to global health projects from the current level of nearly eight billion dollars a year to 16 billion by 2011," followed by "annual increase[s] leading to a six-year total investment of 95 billion dollars."

30 Oct 2009

Medical News

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

FDA approves Covidien's Abbreviated New Drug Application for CII

Women may need smaller dose of H1N1 vaccine

NCI awards $4.8M for project to measure all the proteins in the human body

FDA-approved drug PEG-ADA shows positive results in relieving major complication of priapism

Pfizer and Wyeth enter into supplemental indenture to amend consent solicitation

New York Times examines efforts underway to prevent spread of H1N1 during Hajj

NYBC and its divisions call upon the community to join the fight against cancer by donating blood

BHGI's approach to cancer treatment guidelines for low- and moderate-income countries

ATLANTA-France study of the CATANIA Coronary Stent announced

Grenadian Prime Minister calls for continued investment in Caribbean HIV/AIDS programs

FDA approves an expanded indication for BYETTA injection

Aetna signs new expanded agreement with Sarasota Memorial Hospital

Individualized MicroNutrient Testing for patients

Research suggests the possibility of an effective treatment for Hendra virus infections in humans

Public concern can undermine flu vaccination campaigns

Data from multiple clinical and preclinical studies evaluating Hematide announced

As House bill continues to stir reaction, focus turns to costs, potential amendments

Administration officially ends HIV travel ban

Advocates call for increased U.S. investment in global health

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News